Over 100,000 women in the UK have placed their trust in SheMed for one compelling reason: it treats weight loss as a medical matter, not a willpower problem. The programme combines FDA-approved GLP-1 medications with mandatory at-home blood testing, continuous clinical oversight, and an app-based support system designed specifically for how women’s bodies actually work. Whether you’re managing PCOS, navigating perimenopause, or simply seeking a science-backed path forward, SheMed acknowledges the unique health considerations women face.

This isn’t another fad diet wrapped in modern packaging. The programme’s foundation rests on personalised medical supervision, pharmaceutical evidence, and recognition that female physiology requires tailored approaches. You receive your medications at home, access clinician support through an integrated app, and benefit from a community of women with shared experiences.

Understanding whether SheMed aligns with your health goals requires clarity on how it operates, what medications it prescribes, what it costs, and what real members experience. Explore SheMed’s comprehensive programme details and current offers.

How Medical Supervision Sets SheMed Apart

The medical supervision model differentiates SheMed fundamentally from unmonitored weight loss services. Every participant begins with a compulsory at-home blood test that screens for critical health markers: HbA1c levels, thyroid function, cholesterol, and liver health. These results inform whether GLP-1 treatment suits your individual biology and which medication might work best for you.

This initial testing phase takes several days, which means you won’t receive a prescription immediately. That delay, however, serves a protective purpose. Your clinician reviews your results, considers your medical history, and ensures the treatment aligns with your specific needs rather than applying a one-size-fits-all approach.

Ongoing Monitoring and Personalisation

Supervision doesn’t end once your medication arrives. Clinical oversight continues at key milestones through the integrated app, where you can message clinicians with questions or concerns about side effects, progress, or adjustments to your treatment plan. This real-time communication channel addresses one of the major gaps in traditional weight loss support: the ability to reach a qualified professional when you need guidance.

Personalisation extends beyond initial blood work. Your medication selection and dosing strategy reflect your individual health markers, medical history, and response to treatment. Two women with similar starting weights might receive different medications or dosing schedules based on their thyroid function, insulin resistance patterns, or other metabolic markers.

Understanding GLP-1 Medications: Mounjaro vs. Wegovy

SheMed offers two primary FDA-approved GLP-1 medications, each with distinct mechanisms and pricing structures.

Mounjaro (Tirzepatide): The Dual-Action Approach

Mounjaro represents a newer generation of GLP-1 therapy, working through a dual-action mechanism. It targets two appetite-regulating hormones simultaneously—GLP-1 and GIP—creating a more potent effect on hunger suppression and metabolic regulation. This dual approach often translates to more significant weight loss results compared to single-hormone medications.

Mounjaro pricing through SheMed ranges from £229 to £319 monthly, making it the premium option. The investment reflects its effectiveness and the comprehensive support package accompanying your prescription, including a side-effect care package with sharps bins and over-the-counter remedies for common reactions.

Wegovy (Semaglutide): Accessible and Proven

Wegovy operates as a single-hormone GLP-1 agonist available in both injectable and oral pill formats. The injectable format has established clinical track records spanning years, while the oral pill represents a newer, more convenient option for those who prefer to avoid injections. Wegovy pricing typically ranges from £139 to £239 monthly, with introductory offers starting at £59 for the first month at the lowest dose.

The lower entry price point makes Wegovy an accessible starting point for many women. The medication remains highly effective for weight loss, though the dual-action mechanism of Mounjaro often produces stronger appetite suppression. Both medications integrate with SheMed’s clinical oversight model, ensuring safety regardless of which you choose.

The Role of Female-Specific Health Considerations

SheMed’s women-centric design addresses metabolic and hormonal realities that standard weight loss programmes often overlook.

PCOS and Insulin Resistance

Women with polycystic ovary syndrome (PCOS) frequently experience insulin resistance, making traditional calorie-restriction approaches frustratingly ineffective. GLP-1 therapy directly addresses this underlying metabolic dysfunction by improving insulin sensitivity alongside appetite suppression. SheMed clinicians understand PCOS-specific challenges and can tailor your treatment plan accordingly, potentially yielding weight loss results where previous attempts stalled.

Perimenopause and Metabolic Shifts

The hormonal fluctuations surrounding menopause create metabolic changes that complicate weight management. Declining oestrogen levels slow metabolism, shift fat distribution, and can amplify hunger signals. SheMed’s approach acknowledges these physiological realities rather than attributing weight challenges solely to lifestyle factors. Clinicians familiar with perimenopause-specific metabolic patterns can adjust your treatment as your hormone levels shift, providing stability through a destabilising life stage.

Integrated Nutritional and Community Support

Beyond medication, SheMed’s app delivers female-focused recipe content and nutritional guidance developed specifically for women managing weight loss. The community component connects you with over 100,000 women navigating similar challenges, creating a support network that addresses both physical and psychological dimensions of sustainable weight management. Discover how SheMed’s community support enhances your weight loss journey.

Pricing Transparency and Value Assessment

SheMed operates on a subscription model with transparent monthly costs. Understanding the full investment—beyond just medication prices—helps you evaluate whether the programme aligns with your budget and expectations.

Introductory Offers and Ongoing Costs

Wegovy introductory offers begin at £59 for the first month at the lowest dose, providing an accessible entry point. After the introductory period, Wegovy costs typically settle between £139 and £239 monthly depending on your dose and commitment length. Mounjaro pricing ranges from £229 to £319 monthly. Longer commitment plans occasionally offer slight savings, though month-to-month flexibility remains available.

What’s Included in Your Investment

Your monthly cost covers prescription medication, clinical oversight through app-based messaging, access to the integrated app platform, female-focused content, and a comprehensive side-effect care package. The blood testing that establishes your baseline and informs personalisation happens at the outset, not as ongoing charges. This bundled approach means costs remain relatively predictable month-to-month.

Evaluating Return on Investment

For many women, the monthly cost becomes justifiable when compared against years of ineffective dieting, gym memberships that don’t produce results, or consultation fees with private weight loss clinics charging £200+ per visit. SheMed’s strength lies in combining clinical legitimacy, personalised medication, and ongoing support without requiring separate payments for each component.

Real Member Experiences and Reputation

SheMed maintains a 4-star Trustpilot rating across thousands of reviews, suggesting consistent satisfaction among real users. Members frequently praise prompt service, effective medication delivery, and responsive clinical teams. The expanding 100,000+ member community reflects genuine trust rather than marketing hype.

Positive feedback commonly highlights the relief of receiving medically supervised treatment rather than attempting weight loss independently, the effectiveness of the medications themselves, and the supportive community environment. Members particularly appreciate the female-focused approach, noting that clinicians understand hormonal and physiological factors affecting their weight.

Some users report subscription cancellation challenges, and cost remains a consideration for budget-conscious individuals. A smaller segment experience side effects requiring dose adjustment, though the clinical oversight model addresses these issues through app-based communication and medication tweaks.

Your Path Forward With SheMed

SheMed represents a meaningful shift in how women can approach weight loss—one grounded in medical evidence, personalised to female physiology, and supported by clinical oversight at every step. The combination of FDA-approved medications, mandatory blood testing, and app-based community creates a framework addressing both physical and psychological dimensions of sustainable weight management. For women seeking legitimacy and safety over quick fixes, that investment often translates to real, lasting results.

The programme’s 4-star reputation and 100,000+ member community speak volumes about user experience and effectiveness. Thousands of women have moved beyond yo-yo dieting cycles and discovered what results look like when treatment aligns with how their bodies actually function. If you’re tired of ineffective approaches and ready to work with your biology rather than against it, SheMed’s women-focused model might be exactly the solution you’ve been seeking. Start your SheMed journey today with a free at-home blood test.